Research On Credit Risk Management In Pharmaceutical Enterprises

With the development of our market economy, the competition between enterprises is becoming increasingly fierce, enterprise credit has become an important means to stimulate sales, fully tap the market potential of each industry as a sunrise industry, the pharmaceutical industry is no exception. In rapid economic growth, people’s income and consumption level is also rising, increasing the demand for health, and thus the demand for drugs is greatly increased; in a short period of time the pharmaceutical industry enterprises, pharmaceutical circulation enterprises because of the higher profit to expand sales scale. However, in the rapid development of the pharmaceutical enterprises at the same time, a series of problems are following: the product homogeneity serious, intensified competition in the industry, pharmaceutical resources surplus, resulting in the operation quality and profitability of enterprises are gradually decreased, the survival and development of the serious influence of some pharmaceutical enterprises. At present, the domestic pharmaceutical enterprises profit decline year by year, the average profit rate of industrial enterprises has been reduced to 5%, it is difficult to production and management of industrial enterprise nearly 70%; the average profit rate of the medicine circulation enterprises has dropped to 0.5%, the pharmaceutical distribution business regardless of size, a large part of the enterprise funds are very tight, some already in existence the dilemma.This paper selects the medicine industry of LB company, the company is one of the China large pharmaceutical joint venture, the sales of its products mainly are distributed through the pharmaceutical business channels, products enjoy a high reputation among consumers, some products with a higher share in the market. But the LB company in the rapid development at the same time, it also increase the risk of credit management, product sales growth also brings huge credit risks, how to build a sound credit risk management system has become an urgent need to consider the problem of the company, this topic research has the very strong practical significance. This paper first introduces the theory of enterprise credit risk management, the management of Chinese pharmaceutical enterprises and credit management status is analyzed in detail, according to the management situation of LB company, the establishment of organizational structure of credit management, independent, introduced before, during and after the event, the full control of the credit management system, credit transfer tool application risk, help LB company to establish a scientific, standardized and reasonable credit risk management system and system, which can effectively reduce the company’s credit risk, to ensure the sustained and healthy development of the company, fast.LB is just a microcosm of many pharmaceutical enterprises, the author hope that through the design of LB credit management system and perfect, for the same other pharmaceutical companies in the pharmaceutical industry is to strengthen enterprise credit management, establish a sound credit risk management system which has positive guiding significance.